Home

Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)

0.1052
-0.0021 (-1.96%)
NASDAQ · Last Trade: Nov 14th, 12:52 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.1073
Open0.0940
Bid0.1057
Ask0.1100
Day's Range0.0931 - 0.1200
52 Week Range0.0931 - 9.860
Volume25,009,771
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume16,958,282

Chart

News & Press Releases

12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 13, 2025
These stocks have an unusual volume in today's sessionchartmill.com
Volume analysis on 2025-11-12: stocks with an unusual volume in today's session.
Via Chartmill · November 12, 2025
Top movers in Wednesday's pre-market sessionchartmill.com
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · November 12, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 12, 2025
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 12, 2025
Curious about the most active stocks on Tuesday?chartmill.com
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!
Via Chartmill · November 11, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · November 11, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 11, 2025
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 11, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · November 10, 2025
Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session.chartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · November 10, 2025
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the CPHI Frankfurt trade show, the world's largest pharmaceutical event. The Company engaged in numerous strategic discussions with global pharmaceutical companies regarding technical collaboration and licensing opportunities for its lead product candidate, a novel sublingual high-dose aspirin.
Via ACCESS Newswire · November 6, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · October 28, 2025
Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform
ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery technology. This application - which seeks patent protection of Aspire's proprietary technology in a variety of classes of drugs and other substances--focuses exclusively on protecting the Company's advanced sublingual drug delivery system, which is designed to enhance the pharmacokinetic performance of Active Pharmaceutical Ingredients ("APIs") and other substances into the bloodstream, increasing bioavailability and improving speed of onset.
Via ACCESS Newswire · October 6, 2025
Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025
Showcasing Disruptive Sublingual Drug Delivery Technology with Lead Program Targeting H2 2025 FDA Submission for Sublingual Aspirin
Via ACCESS Newswire · October 3, 2025
These stocks are gapping in today's sessionchartmill.com
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 3, 2025
These stocks that are showing activity before the opening bell on Friday.chartmill.com
Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Via Chartmill · October 3, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 3, 2025
Why Actelis Networks Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 3, 2025
Thursday's after hours session: top gainers and loserschartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · October 2, 2025
Crude Oil Down 2%; Aspire Biopharma Shares Spike Higherbenzinga.com
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500 also rose, gaining, 0.07% to 6,715.87.
Via Benzinga · October 2, 2025
Discover the most active stocks in Thursday's session.chartmill.com
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · October 2, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 2, 2025
Here are the top movers in Thursday's session.chartmill.com
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · October 2, 2025
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Resultsbenzinga.com
Via Benzinga · October 2, 2025